What is a suitable tapering regimen for a patient on 40mg of prednisone (corticosteroid)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prednisone 40mg Tapering Regimen

For a patient on 40mg of prednisone, the recommended tapering regimen is to reduce the dose by 5mg every week until reaching 10mg/day, then reduce by 2.5mg every week until discontinuation, while monitoring for signs of disease recurrence or adrenal insufficiency. 1

Initial Tapering Phase

  • Begin with 40mg daily dose (preferably taken in the morning before 9am to minimize adrenal suppression) 1
  • Reduce dose by 5mg every week until reaching 10mg/day 2
    • Week 1: 40mg/day
    • Week 2: 35mg/day
    • Week 3: 30mg/day
    • Week 4: 25mg/day
    • Week 5: 20mg/day
    • Week 6: 15mg/day
    • Week 7: 10mg/day

Secondary Tapering Phase

  • Once at 10mg/day, slow the taper to 2.5mg reductions every week 2
    • Week 8: 7.5mg/day
    • Week 9: 5mg/day
    • Week 10: 2.5mg/day
    • Week 11: Discontinue

Important Considerations

  • Never stop prednisone abruptly as this can lead to adrenal crisis 1

  • The tapering schedule must be individualized based on:

    • The underlying condition being treated 2
    • Duration of previous steroid therapy (patients on steroids >3 weeks are at risk for hypothalamic-pituitary-adrenal axis suppression) 2
    • Patient's response to dose reduction 1
  • For patients with autoimmune conditions, a more gradual taper may be necessary, with longer periods at each dose level 2

  • For conditions like polymyalgia rheumatica, after reaching 5mg/day, consider maintaining this dose for a longer period (up to a year) before final tapering 2, 3

Monitoring During Tapering

  • Monitor for signs of disease relapse at each dose reduction 2
  • Watch for symptoms of adrenal insufficiency: fatigue, weakness, dizziness, nausea, hypotension 2
  • Follow-up visits every 4-8 weeks during the first year of treatment 2
  • Patients should be educated about stress dosing for illness or surgery 2

Special Situations

  • For severe inflammatory conditions (like autoimmune hepatitis), the taper may need to be slower, with dose reductions every 4 weeks rather than weekly 2

  • For short-term treatment of acute conditions (like asthma exacerbations), faster tapering or even abrupt discontinuation after 7-10 days may be appropriate 4, 5, 6

  • For patients at high risk of relapse, consider adding steroid-sparing agents before beginning the taper 2

Stress Dosing During Tapering

  • Patients undergoing significant stress (surgery, severe illness) may require temporary return to higher doses 2
  • For minor stress, double the current daily dose for the duration of illness 2
  • For major stress, consider IV hydrocortisone (starting with 50-100mg every 6-8 hours) 2

Minimizing Steroid Complications

  • Consider calcium and vitamin D supplementation to prevent osteoporosis 2
  • Monitor for steroid-induced diabetes, hypertension, and weight gain 2
  • Morning dosing (before 9am) helps minimize adrenal suppression 1

Remember that successful tapering depends on careful monitoring and adjustment based on both objective measures of disease activity and signs of adrenal insufficiency. The goal is to use the minimum effective dose for the shortest possible time while avoiding disease relapse and withdrawal symptoms.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Evaluating an alternative oral regimen for the treatment of polymyalgia rheumatica.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2000

Research

Double-blind trial of steroid tapering in acute asthma.

Lancet (London, England), 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.